XML 41 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plan
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plan

NOTE 16 - EQUITY INCENTIVE PLAN

At the Company’s 2014 annual meeting, the shareholders adopted the Company’s 2014 Incentive Plan (“2014 Incentive Plan”). The 2014 Incentive Plan authorizes the Company to grant options, stock awards, stock units and other awards for up to 375,000 common shares of the Company. There were 117,662 shares available for grants under this plan at December 31, 2022.

No options had been granted under the 2014 Incentive Plan as of December 31, 2022 and 2021.

In recent years, the Board of Directors has awarded restricted common shares to senior officers of the Company. The restricted shares vest ratably over a three-year period following the grant date. The product of the number of restricted shares granted and the grant date market price of the Company’s common shares determines the fair value of restricted shares under the Company’s 2014 Incentive Plan. Management recognizes compensation expense for the fair value of restricted shares on a straight-line basis over the requisite service period for the entire award.

During the twelve months ended December 31, 2022, 2021 and 2020, directors of the Company’s banking subsidiary, Civista, were paid a retainer in the form of non-restricted common shares of the Company. An aggregate of 8,098, 8,792 and 14,266 common shares were issued to Civista directors in 2022, 2021 and 2021, respectively, as payment of their retainer for their service on the Civista Board of Directors. The issuances were expensed in their entirety when the shares were issued in the amounts of $189, $196 and $196, respectively.

The Company includes share-based compensation for employees as “Compensation expense” in the Consolidated Statements of Operations.

NOTE 16 - EQUITY INCENTIVE PLAN (Continued)

The following is a summary of the status of the Company’s restricted shares, and changes therein during the twelve months ended December 31, 2022:

 

 

 

December 31, 2022

 

 

 

Number of
Restricted
Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Nonvested at beginning of period

 

 

69,840

 

 

$

20.14

 

Granted

 

 

31,774

 

 

 

24.51

 

Vested

 

 

(27,728

)

 

 

24.28

 

Forfeited

 

 

(3,411

)

 

 

21.88

 

Nonvested at end of period

 

 

70,475

 

 

 

21.88

 

 

The following is a summary of the status of the Company’s awarded restricted shares as of December 31, 2022:

 

At December 31, 2022

 

Date of Award

 

Shares

 

 

Remaining Expense

 

 

Remaining Vesting Period (Years)

 

April 10, 2018

 

 

1,470

 

 

$

 

 

 

0.00

 

March 14, 2019

 

 

4,034

 

 

 

40

 

 

 

1.00

 

March 14, 2020

 

 

4,304

 

 

 

 

 

 

0.00

 

March 14, 2020

 

 

6,669

 

 

 

90

 

 

 

2.00

 

March 3, 2021

 

 

10,858

 

 

 

150

 

 

 

3.00

 

March 3, 2021

 

 

13,692

 

 

 

131

 

 

 

1.00

 

March 3, 2022

 

 

12,424

 

 

 

236

 

 

 

4.00

 

March 3, 2022

 

 

17,024

 

 

 

258

 

 

 

2.00

 

 

 

 

70,475

 

 

$

905

 

 

 

2.09

 

 

During the twelve months ended December 31, 2022, 2021 and 2020, the Company recorded share-based compensation expense of $630, $506 and $421, respectively, and director retainer fees of $189, $196 and $196, respectively, for shares granted under the 2014 Incentive Plan. At December 31, 2022, the total compensation cost related to unvested awards not yet recognized was $905, which is expected to be recognized over the weighted average remaining life of the grants of 2.09 years.